Question follow-through · 49662
Care Homes: Drugs
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of regulation of access to controlled drugs in care homes in North Somerset.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 30 Apr 2025
- Target answer date
- 6 May 2025
- Answer
- 8 May 2025 · 8 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Health Services · 12 May 2025
- NHS England: Drugs · 22 May 2025
- Life Sciences · 22 May 2025
- Health Services · 3 Jun 2025
- Pharmacy: Fees and Charges · 3 Jun 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
30 Apr 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of regulation of access to controlled drugs in care homes in North Somerset.
6 May 2025
Target answer date
Date supplied by the official written-questions record.
8 May 2025
Answer published
Under the Enhanced health in care homes framework, every care home must be aligned to a primary care network (PCN) and must have established protocols between the PCN, the care home, and system partners, such as local general practices and pharmacies, for...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Health Services
12 May 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to include policies on self-care within the forthcoming 10-year Health Plan.
NHS England: Drugs
22 May 2025 · To ask the Secretary of State for Health and Social Care, how many commercial agreements NHS England has made with manufacturers of medicines which have r resulted in indication-specific pricing between January 2020 and March 2025; and what therapeutic ar
Life Sciences
22 May 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of NHS England’s criterion for eligibility for indication-specific pricing to demonstrate revenue loss on the UK’s international competitiveness
Health Services
3 Jun 2025 · To ask the Secretary of State for Health and Social Care, pursuant to his Answer of 16 May 2025 to Question 51728, what steps he is taking to ensure that patients (a) improve and (b) protect their own health.
Pharmacy: Fees and Charges
3 Jun 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to prevent spoke pharmacies from charging patients for additional services which are delivered by an outsourced hub partner.
Nurses: Schools
10 Jun 2025 · To ask the Secretary of State for Health and Social Care, how many and what proportion of school nurses have received specialist training in (a) allergy and (b) anaphylaxis management.
Bladder Cancer: Health Services
23 Jun 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of care for bladder cancer in each region; and if he will hold discussions with NICE guidelines on the time taken to update its guidelines on
Respiratory Syncytial Virus: Vaccination
24 Jun 2025 · To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of (a) hospitalisations and (b) deaths that have been prevented by RSV vaccines administered through the early adopter community pharmacy sites.
Pharmacy: Training
24 Jun 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure a sufficient number of Designated Prescribing Practitioners to mentor all new non-medical prescribers.
NHS: Drugs
18 Jul 2025 · To ask the Secretary of State for Health and Social Care, with reference to Action 28 (i) of the Life Sciences Sector Plan, published on 16 July 2025, what criteria his Department plans to use to identify which medicines have a large number of indications
NHS: Drugs
18 Jul 2025 · To ask the Secretary of State for Health and Social Care, with reference to Action 28 (i) of the Life Sciences Sector Plan, published on 16 July 2025, what criteria his Department plans to use to identify (a) low affordability risk and (b) strong long-ter
Cancer: Drugs
18 Jul 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2025 to Question 54542 on Drug Prices, how many of the commercial arrangements involving indications-specific pricing were for indications for (a) rare and (b) ult